Paper3534840
Calcium antagonists and chronic cardiac failure.
Kendall MJ and 2 others. Postgrad Med J, 1986. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Calcium antagonists and chronic cardiac failure. Papers, record 3534840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3534840
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Channel Blockers | Major topic |
| Heart Failure | Major topic |
| Chronic Disease | |
| Diltiazem | |
| Humans | |
| Nifedipine | |
| Verapamil |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 365390 | Effects of verapamil on myocardial performance in coronary disease. | Circulation | 1979 | https://conductscience.org/library/papers/365390 | PubMed |
| 2 | 2864977 | Treatment of chronic heart failure: a review of recent drug trials. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/2864977 | PubMed |
| 3 | 6767986 | Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6767986 | PubMed |
| 4 | 6250739 | Therapeutic implications of slow-channel blockade in cardiocirculatory disorders. | Circulation | 1980 | https://conductscience.org/library/papers/6250739 | PubMed |
| 5 | 7415993 | Hemodynamic effects of nifedipine in congestive heart failure. | Am J Cardiol | 1980 | https://conductscience.org/library/papers/7415993 | PubMed |
| 6 | 7437785 | Unpredictable response to nifedipine in severe cardiac failure. | Br Med J | 1980 | https://conductscience.org/library/papers/7437785 | PubMed |
| 7 | 7004158 | The clinical use of intravenous verapamil. | Am Heart J | 1980 | https://conductscience.org/library/papers/7004158 | PubMed |
| 8 | 7211708 | Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. | Am J Cardiol | 1981 | https://conductscience.org/library/papers/7211708 | PubMed |
| 9 | 7237897 | Verapamil disposition kinetics in chronic atrial fibrillation. | Clin Pharmacol Ther | 1981 | https://conductscience.org/library/papers/7237897 | PubMed |
| 10 | 7053285 | The 24-hour ambulatory blood pressure profile with verapamil. | Circulation | 1982 | https://conductscience.org/library/papers/7053285 | PubMed |
| 11 | 7318906 | Calcium antagonists prevent early post-infarction ventricular fibrillation. | Eur J Pharmacol | 1981 | https://conductscience.org/library/papers/7318906 | PubMed |
| 12 | 7055871 | Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. | Circulation | 1982 | https://conductscience.org/library/papers/7055871 | PubMed |
| 13 | 7038491 | Nifedipine in unstable angina: a double-blind, randomized trial. | N Engl J Med | 1982 | https://conductscience.org/library/papers/7038491 | PubMed |
| 14 | 7051138 | Clinical manifestations and pathophysiology of myocardial ischemia with special reference to coronary artery spasm and the role of slow channel calcium blockers. | Prog Cardiovasc Dis | 1982 | https://conductscience.org/library/papers/7051138 | PubMed |
| 15 | 6753557 | Rationale for the choice of calcium antagonists in chronic stable angina. An objective double-blind placebo-controlled comparison of nifedipine and verapamil. | Am J Cardiol | 1982 | https://conductscience.org/library/papers/6753557 | PubMed |
| 16 | 6849223 | The effects of nifedipine, a calcium antagonist, on platelet function. | Am Heart J | 1983 | https://conductscience.org/library/papers/6849223 | PubMed |
| 17 | 6681931 | Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. | Am J Cardiol | 1983 | https://conductscience.org/library/papers/6681931 | PubMed |
| 18 | 6846159 | Nifedipine tablets for systemic hypertension: a study using continuous ambulatory intraarterial recording. | Am J Cardiol | 1983 | https://conductscience.org/library/papers/6846159 | PubMed |
| 19 | 6846161 | Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure. | Am J Cardiol | 1983 | https://conductscience.org/library/papers/6846161 | PubMed |
| 20 | 6851041 | Short- and long-term efficacy of high-dose oral diltiazem for angina due to coronary artery disease: a placebo-controlled, randomized, double-blind crossover study. | Circulation | 1983 | https://conductscience.org/library/papers/6851041 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 1720378 | Calcium antagonists in patients with heart failure. A review. | Drugs | 1991 | https://conductscience.org/library/papers/1720378 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3534840
GET https://conductscience.org/api/papers/v1/3534840/references?page=2